Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company
What total market size is anticipated for the Point-of-Care (POC) Coagulation Testing Market in 2030?
The point-of-care (poc) coagulation testing market size has consistently expanded in recent years. It is projected to grow from $1.25 billion in 2025 to $1.3 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.2%. This historical growth can be attributed to the increasing prevalence of cardiovascular diseases that necessitate anticoagulation therapy, a higher demand for rapid coagulation results in operating rooms and ICUs, the early clinical uptake of optical and mechanical point-of-care testing platforms, the wider implementation of coagulation monitoring across hospital and clinic settings, and greater awareness of point-of-care diagnostics for refining treatment.
The point-of-care (poc) coagulation testing market size is anticipated to demonstrate consistent expansion over the coming years. By 2030, this market is projected to reach $1.52 billion, advancing at a compound annual growth rate (CAGR) of 4.1%. This growth during the forecast period is propelled by factors such as a growing move towards decentralized and home-based coagulation monitoring, increased adoption of electrochemical detection technologies, higher procedure volumes in emergency and trauma care environments, broadened access via retail and direct tender distribution channels, and a stronger emphasis on reducing turnaround times and improving therapy outcomes. Prominent trends for the forecast period include the rising implementation of rapid bedside coagulation testing in critical and emergency care settings, the expanded deployment of poc coagulation devices for anticoagulation therapy monitoring, a growing preference for portable and handheld coagulation analyzers, the wider application of coagulation testing in home care and outpatient settings, and an increasing need for real-time clinical decision support facilitated by near-patient testing.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13913&type=smp
What Drivers Are Influencing Production Trends In The Point-of-Care (POC) Coagulation Testing Market?
The increasing prevalence of cardiovascular diseases is anticipated to fuel expansion in the point-of-care (POC) coagulation testing market. Cardiovascular diseases (CVDs) encompass various conditions affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease, and peripheral arterial disease. Point-of-care (POC) coagulation testing offers crucial support in managing CVDs by delivering real-time insights into a patient’s coagulation status, thus enabling prompt interventions and mitigating the risk of hemorrhage following cardiac operations. For example, data from October 2024 by the Centers for Disease Control and Prevention revealed that in 2023, approximately 1 out of every 6 deaths due to cardiovascular diseases occurred in adults younger than 65 years old, and overall, 919,032 individuals succumbed to cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the growing occurrence of cardiovascular diseases is a key factor propelling the point-of-care (POC) coagulation testing market forward.
Which Segment Groups Are Influencing The Point-of-Care (POC) Coagulation Testing Market?
The point-of-care (poc) coagulation testing market covered in this report is segmented –
1) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
2) By Distribution Channel: Direct Tenders, Retail
3) By End-User: Hospitals, Clinics, Home care
Subsegments:
1) By Optical Technology: Reflectance Photometry, Fluorescence Detection, Colorimetric Detection
2) By Mechanical Technology: Mechanical Oscillation, Ultrasonic Detection
3) By Electrochemical Technology: Amperometric Detection, Potentiometric Detection, Conductometric Detection
What Long-Term Trends Are Expected To Shape The Future Of The Point-of-Care (POC) Coagulation Testing Market?
Leading companies within the point-of-care (POC) coagulation testing market are concentrating on developing innovative connected POC coagulation solutions by engaging in strategic collaborations to secure a competitive advantage. A strategic collaboration is defined as a formal pact between two or more entities that agree to cooperate in achieving specific, pre-established, and mutually beneficial goals. For example, in January 2023, Jana care, a US-based company focused on creating biomarker assays for its proprietary digital health platform, partnered with Roche Diagnostics, a Switzerland-based company that develops diagnostic tests, instruments, and digital solutions designed to transform healthcare. This collaboration seeks to create and distribute a point-of-care blood testing platform specifically for screening chronic kidney disease and heart failure. This innovative platform will empower patients to conduct blood tests in their homes, with clinicians remotely reviewing the outcomes.
Who Are The Top-Performing Companies In The Point-of-Care (POC) Coagulation Testing Market In Recent Years?
Major companies operating in the point-of-care (poc) coagulation testing market are Siemens Healthcare GmbH, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, Sysmex Corporation, IDEXX Laboratories Inc., Quidel Corporation, Werfen SA, Nihon Kohden Corporation, Horiba Ltd., Hycel, Nova Biomedical Corporation, Haemonetics Corporation, Maccura Biotechnology Co. Ltd., Helena Laboratories Corporation, Abaxis Inc., ARKRAY Inc., Radiometer Medical ApS, HemoSonics LLC, iLine Microsystems SL, Corgenix Medical Corporation, Quotient Limited, Micropoint Bioscience Inc., Beijing Succeeder Technology Inc., EKF Diagnostics Holdings plc
Access The Complete Report For Deeper Market Insights:
How Does The Point-of-Care (POC) Coagulation Testing Market Perform Across Major Global Regions?
North America was the largest region in the point-of-care (POC) coagulation testing market in 2025. The regions covered in the point-of-care (poc) coagulation testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Point-of-Care (POC) Coagulation Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13913&type=smp
Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Market 2026, By The Business Research Company
Point Of Care Poc Coagulation Testing Global Market Report 2026
Point Of Care Diagnostics Devices And Equipment Global Market Report 2026
Point Of Care Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/point-of-care-diagnostics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company